Insider Shareholders with Direct Ownership of Teva Pharmaceutical Industries LTD (TEVA)
This section provides a comprehensive overview of the insiders with direct ownership of Teva Pharmaceutical Industries LTD (TEVA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
TEVA PHARMACEUTICAL INDUSTRIES LTD Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 70,106 | 0 | 2,094,331 $33.7 Million | 5 |
Jun 15, 2024
Added 1.0%
|
|
| 70,106 | 0 | 1,595,683 $25.7 Million | 5 |
Jun 15, 2024
Added 1.31%
|
|
|
Kare Schultz
President and CEO |
1,451,991 | 0 | 1,542,471 $24.8 Million | 11 |
Nov 01, 2022
Added 7.02%
|
| 869,031 | 404,870 | 488,911 $7.87 Million | 22 |
Mar 05, 2025
Added 4.64%
|
|
|
Eliyahu Sharon Kalif
EVP, Chief Financial Officer |
682,988 | 223,925 | 459,063 $7.39 Million | 20 |
Mar 05, 2025
Added 4.45%
|
| 131,681 | 0 | 409,114 $6.59 Million | 5 |
Jun 15, 2024
Added 8.42%
|
|
|
Richard D Francis
President and CEO |
507,995 | 236,212 | 271,783 $4.38 Million | 11 |
Mar 05, 2025
Reduced 2.95%
|
|
Sven Dethlefs
EVP, North America Commercial |
345,476 | 200,734 | 165,381 $2.66 Million | 22 |
Mar 07, 2023
Reduced 25.99%
|
|
Eric Drape
Executive VP Global Operations |
491,459 | 367,038 | 145,915 $2.35 Million | 31 |
Mar 05, 2024
Added 27.46%
|
| 70,106 | 0 | 106,025 $1.71 Million | 5 |
Jun 15, 2024
Added 16.6%
|
|
| 70,106 | 0 | 103,615 $1.67 Million | 5 |
Jun 15, 2024
Added 16.92%
|
|
|
Dov Bergwerk
Acting Chief Legal Officer |
6,653 | 0 | 96,983 $1.56 Million | 1 |
Feb 28, 2024
Added 6.42%
|
| 70,106 | 0 | 95,683 $1.54 Million | 5 |
Jun 15, 2024
Added 18.07%
|
|
| 70,656 | 0 | 88,277 $1.42 Million | 5 |
Jun 15, 2024
Added 19.3%
|
|
| 64,065 | 0 | 64,065 $1.03 Million | 4 |
Jun 15, 2024
Added 24.78%
|
|
|
Jean Michel Halfon
Director |
33,188 | 0 | 63,707 $1.03 Million | 3 |
Jun 14, 2022
Added 18.52%
|
|
Nechemia Jacob Peres
Director |
33,188 | 0 | 58,765 $946,116 | 3 |
Jun 14, 2022
Added 19.77%
|
|
Christine Fox
EVP, Head of U.S. Commercial |
83,953 | 25,569 | 58,384 $939,982 | 5 |
Mar 05, 2025
Reduced 3.55%
|
|
Eli Shani
EVP,Global Marketing&Portfolio |
50,448 | 5,311 | 54,228 $873,070 | 8 |
Mar 05, 2023
Added 9.81%
|
| 49,123 | 0 | 49,140 $791,154 | 3 |
Jun 15, 2024
Added 30.05%
|
|
|
Richard Daniell
Exec. VP, European Commercial |
881,608 | 843,988 | 48,384 $778,982 | 36 |
Mar 05, 2025
Reduced 50.0%
|
|
Galia Inbar
Officer |
41,183 | 0 | 46,011 $740,777 | 5 |
Mar 05, 2023
Added 11.04%
|
|
Amir Weiss
Chief Accounting Officer |
77,741 | 61,882 | 30,250 $487,025 | 18 |
Mar 05, 2025
Added 10.55%
|
|
Brendan P. O'Grady
EVP, North America Commercial |
128,977 | 128,977 | 14,868 $239,374 | 10 |
Mar 05, 2021
Reduced 43.48%
|
| 12,872 | 0 | 12,872 $207,239 | 1 |
Sep 02, 2024
Added 50.0%
|
|
|
David R. Mc Avoy
EVP, Chief Legal Officer |
16,741 | 4,827 | 11,914 $191,815 | 3 |
Mar 05, 2025
Reduced 12.34%
|
|
Angus Grant
EVP, Business Development |
12,913 | 4,065 | 8,848 $142,452 | 2 |
Aug 09, 2024
Reduced 31.48%
|
|
David Matthew Stark
Exec. VP Chief Legal Officer |
371,867 | 371,867 | 2,974 $47,881 | 25 |
Mar 07, 2023
Reduced 94.33%
|
|
Hafrun Fridriksdottir
Executive VP, Global R&D |
299,758 | 349,232 | 1,386 $22,314 | 21 |
May 17, 2022
Reduced 98.95%
|
| 178,535 | 178,535 | 0 $0 | 12 |
Mar 05, 2025
Reduced 100.0%
|
|
|
Gianfranco Nazzi
EVP, International Markets |
91,713 | 111,557 | 0 $0 | 8 |
Mar 04, 2021
Reduced 100.0%
|
| 21,544 | 21,544 | 0 $0 | 8 |
May 13, 2024
Reduced 100.0%
|